Table 1 Clinical characteristics of the patients with rheumatoid arthritis
Patient | Disease duration (months) | Site of surgery | Gender | Medication |
|---|---|---|---|---|
1 | 180 | Knee | Female | Prednisolone, 5 mg/d; celecoxib, 200 mg/d; gasmotine, 2.5 mg/d |
2 | 36 | Knee | Female | Cyclosporin A, 100 mg/d; triamcinolone, 2 mg/d |
3 | 240 | Knee | Male | Prednisolone, 5 mg/d; hydroxychloroquine, 200 mg/d; sulfasalazine, 500 mg/d |
4 | 180 | Hip | Female | Hydroxychloroquine, 200 mg/d |
5 | 187 | Knee | Female | Deflazacort, 5 mg/d; methotrexate, 12.5 mg/wk; leflunomide, 10 mg/d; hydroxychloroquine, 200 mg/d |